These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1757215)

  • 1. Effects of monosialoganglioside GM1 in experimental models of ischemic brain damage.
    Lipartiti M; Lazzaro A; Zanoni R; Bonvento G; Mazzari S
    Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):11-3. PubMed ID: 1757215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monosialoganglioside GM1 reduces NMDA neurotoxicity in neonatal rat brain.
    Lipartiti M; Lazzaro A; Zanoni R; Mazzari S; Toffano G; Leon A
    Exp Neurol; 1991 Sep; 113(3):301-5. PubMed ID: 1915720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monosialoganglioside GM1 in cerebral ischemia.
    Carolei A; Fieschi C; Bruno R; Toffano G
    Cerebrovasc Brain Metab Rev; 1991; 3(2):134-57. PubMed ID: 1854596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosialoganglioside effects following cerebral ischemia: relationship with anti-neuronotoxic and pro-neuronotrophic effects.
    Lipartiti M; Seren MS; Lazzaro A; Koga T; Mazzari S; Facci L; Fusco M; Toffano G; Leon A
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):489-94. PubMed ID: 2130663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM1 reduces infarct volume after focal cerebral ischemia.
    Lazzaro A; Seren MS; Koga T; Zanoni R; Schiavo N; Manev H
    Exp Neurol; 1994 Feb; 125(2):278-85. PubMed ID: 8313942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monosialoganglioside GM1 reduces ischemia--reperfusion-induced injury in the rat retina.
    Weber M; Mohand-Said S; Hicks D; Dreyfus H; Sahel JA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):267-73. PubMed ID: 8603830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain.
    Mahadik SP; Mukherjee S
    Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.
    Garofalo L; Cuello AC
    J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory amino acid neurotoxicity in cultured retinal neurons: involvement of N-methyl-D-aspartate (NMDA) and non-NMDA receptors and effect of ganglioside GM1.
    Facci L; Leon A; Skaper SD
    J Neurosci Res; 1990 Oct; 27(2):202-10. PubMed ID: 2174980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effects of GM1 in experimental cerebral focal ischemia in rabbits.
    Bo P; Marchioni E; Soragna D; Savoldi F
    Boll Soc Ital Biol Sper; 1993 Nov; 69(11):705-10. PubMed ID: 8060600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
    Garofalo L; Cuello AC
    Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulated monosialoganglioside GM1: physical properties and in vivo effects.
    Maysinger D; Jalsenjak V; Stolnik S; Garofalo L; Cuello AC; Jalsenjak I
    J Microencapsul; 1989; 6(1):35-42. PubMed ID: 2715912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of ischemic brain damage by nitrous oxide and xenon.
    David HN; Leveille F; Chazalviel L; MacKenzie ET; Buisson A; Lemaire M; Abraini JH
    J Cereb Blood Flow Metab; 2003 Oct; 23(10):1168-73. PubMed ID: 14526227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New perspectives in the treatment of hypoxic and ischemic brain damage: effect of gangliosides.
    Rotondo G; Maniero G; Toffano G
    Aviat Space Environ Med; 1990 Feb; 61(2):162-4. PubMed ID: 2178600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1.
    Casamenti F; Milan F; Pepeu G
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some functional consequences of chronic GM1 ganglioside administration in brain damaged rats.
    Stein DG
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):405-13. PubMed ID: 2130658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gangliosides and neurotrophic factors in neurodegenerative diseases: from experimental findings to clinical perspectives.
    Fusco M; Vantini G; Schiavo N; Zanotti A; Zanoni R; Facci L; Skaper SD
    Ann N Y Acad Sci; 1993 Sep; 695():314-7. PubMed ID: 8239303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with PTD-calbindin D 28k alleviates rat brain injury induced by ischemia and reperfusion.
    Fan Y; Shi L; Gu Y; Zhao Y; Xie J; Qiao J; Yang GY; Wang Y; Lu CZ
    J Cereb Blood Flow Metab; 2007 Apr; 27(4):719-28. PubMed ID: 16868556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
    Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic ethanol administration sensitizes hippocampal neurons to neurotoxicity of N-methyl-D-aspartic acid.
    Davidson M; Wilce PA; Shanley BC
    Alcohol Alcohol Suppl; 1993; 2():365-9. PubMed ID: 7748324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.